中文版 | English

在结果中检索

IMR OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

已选(0)清除 条数/页：   排序方式：
In Situ Conversion of Artificial Proton-Rich Shell to Inorganic Maskant Toward Stable Single-Crystal Ni-Rich Cathode 期刊论文
ADVANCED MATERIALS, 2024, 页码: 11
作者:  Xue, Haoyu;  Liang, Yongzhi;  Huang, Yuxiang;  Ji, Yuchen;  Xu, Zhongxing;  Chen, Xinhan;  Wang, Honghao;  Liu, Jiajie;  Amine, Khalil;  Liu, Tongchao;  Tan, Xinghua;  Pan, Feng
收藏  |  浏览/下载：2/0  |  提交时间：2025/04/27
dense maskant  electrochemical conversion  LiF and Li3PO4 sub-nano particle  nickel-rich single crystal  proton  
Ti-Gradient Doping to Stabilize Layered Surface Structure for High Performance High-Ni Oxide Cathode of Li-Ion Battery 期刊论文
ADVANCED ENERGY MATERIALS, 2019, 页码: 9
作者:  Kong, Defei;  Hu, Jiangtao;  Chen, Zhefeng;  Song, Kepeng;  Li, Cheng;  Weng, Mouyi;  Li, Maofan;  Wang, Rui;  Liu, Tongchao;  Liu, Jiajie;  Zhang, Mingjian;  Xiao, Yinguo;  Pan, Feng
收藏  |  浏览/下载：126/0  |  提交时间：2021/02/02
disordered layered phase  high-Ni layered oxide  Li-ion batteries  stable surface  Ti-gradient doping  
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi;  Zheng Mingyue;  Zhao Dongmei;  Cheng Maosheng;  Geng Meiyu;  Shen Jingkang;  Ai Jing;  Xiong Bing
收藏  |  浏览/下载：156/0  |  提交时间：2021/02/02
RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery  
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi;  Zheng Mingyue;  Zhao Dongmei;  Cheng Maosheng;  Geng Meiyu;  Shen Jingkang;  Ai Jing;  Xiong Bing
收藏  |  浏览/下载：132/0  |  提交时间：2021/02/02
RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery